Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival : vimarsana.com

J&J’s cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai’s approach to...

Related Keywords

Philadelphia , Pennsylvania , United States , Japan , Bruce Darrow , Kelly Shi , David Reich , Bristol Myers Abecma , Jefferie Shi , Bristol Myers , Rick Bienkowski , Laurie Margolies , Kelsey Goodwin , Cantor Fitzgerald , Mount Sinai Health System , Johnson , Bristol Myers Squibb , Drug Administration On , Reuters , Drug Administration , Legend Biotech , Mount Sinai , Mount Sinai Hospital , Mount Sinai Queens , News ,